DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
OTO-104 is an investigational drug.
There have been 23 clinical trials for OTO-104. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2015.
The most common disease conditions in clinical trials are Meniere Disease, Otitis, and Otitis Media. The leading clinical trial sponsors are Otonomy, Inc., Assiut University, and OHSU Knight Cancer Institute.
There are two US patents protecting this investigational drug and forty-four international patents.
Recent Clinical Trials for OTO-104
|OTO-413 in Subjects With Speech-in-Noise Hearing Impairment||Otonomy, Inc.||Phase 1/Phase 2|
|OTO-313 in Subjects With Subjective Tinnitus||Otonomy, Inc.||Phase 1/Phase 2|
|Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease||Otonomy, Inc.||Phase 3|
Top disease conditions for OTO-104
Top clinical trial sponsors for OTO-104
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|OTO-104||Start Trial||11-substituted bile acid derivatives, process for the preparation thereof and use of these compounds as medicaments||Council of Scientific and Industrial Research (New Delhi, IN)||Start Trial|
|OTO-104||Start Trial||Low, immune enhancing, dose mtor inhibitors and uses thereof||Novartis AG (Basel, CH)||Start Trial|
|OTO-104||Start Trial||Therapeutic compounds and methods of use thereof||GENENTECH, INC. (South San Francisco, CA) XENON PHARMACEUTICALS INC. (Burnaby, BC, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|OTO-104||World Intellectual Property Organization (WIPO)||2015087340||1989-12-31||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|